{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:27:38Z","timestamp":1794436058417,"version":"4.9.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.euf.2026.04.006","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:02:01Z","timestamp":1777600921000},"page":"628-630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201cPro\/ \u2018Yes\u2019 for PSA Testing Before BPO Surgical Therapy\u201d Ignoring PSA in BPE is Not Progress; It\u2019s Clinical Blindness"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5009-8435","authenticated-orcid":false,"given":"Selcuk","family":"Guven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas RW","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2026.04.006_b0005","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s00345-017-2048-y","article-title":"\u201cFinding the needle in a haystack\u201d: oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP)","volume":"35","author":"Herlemann","year":"2017","journal-title":"World J Urol"},{"issue":"Suppl. 3","key":"10.1016\/j.euf.2026.04.006_b0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1464-410X.2008.07497.x","article-title":"BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF\u2010ONE","volume":"101","author":"Roehrborn","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.euf.2026.04.006_b0015","unstructured":"EAU Guidelines. ed. 2026. Arnhem, The Netherlands: EAU Guidelines Office; 2026."},{"key":"10.1016\/j.euf.2026.04.006_b0020","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0090-4295(98)00655-4","article-title":"Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia","volume":"53","author":"Roehrborn","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.euf.2026.04.006_b0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/00365590500497960","article-title":"Relation between acute urinary retention, chronic prostatic inflammation and accompanying elevated prostate-specific antigen","volume":"40","author":"Kefi","year":"2006","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.euf.2026.04.006_b0030","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1089\/end.2005.19.550","article-title":"Change in serum prostate specific antigen concentration after holmium laser enucleation of the prostate: a marker for completeness of adenoma resection?","volume":"19","author":"Tinmouth","year":"2005","journal-title":"J Endourol"},{"key":"10.1016\/j.euf.2026.04.006_b0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/iju.15315","article-title":"Prostate-specific antigen follow-up and management for patients undergoing holmium laser enucleation of the prostate","volume":"31","author":"Kimura","year":"2024","journal-title":"Int J Urol"},{"key":"10.1016\/j.euf.2026.04.006_b0040","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1007\/s00345-020-03444-0","article-title":"Changes in serum PSA after endoscopic enucleation of the prostate are predictive for the future diagnosis of prostate cancer","volume":"39","author":"Lambert","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2026.04.006_b0045","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/JU.0000000000000530","article-title":"The role of prostate specific antigen monitoring after holmium laser enucleation of the prostate","volume":"203","author":"Abedali","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2026.04.006_b0050","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00345-021-03771-w","article-title":"Are all procedures for benign prostatic hyperplasia created equal? A systematic review on post-procedural PSA dynamics and its correlation with relief of bladder outlet obstruction","volume":"40","author":"Bhat","year":"2022","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2026.04.006_b0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.urology.2008.10.062","article-title":"Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia","volume":"74","author":"Helfand","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.euf.2026.04.006_b0060","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1089\/end.2015.0060","article-title":"Reoperation after holmium laser enucleation of the prostate for management of benign prostatic hyperplasia: assessment of risk factors with time to event analysis","volume":"29","author":"Elkoushy","year":"2015","journal-title":"J Endourol"},{"key":"10.1016\/j.euf.2026.04.006_b0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00345-021-03756-9","article-title":"Incidence, predictive factors and oncological outcomes of incidental prostate cancer after endoscopic enucleation of the prostate: a systematic review and meta-analysis","volume":"40","author":"Cheng","year":"2022","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2026.04.006_b0070","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1089\/end.2022.0571","article-title":"Holmium laser enucleation of prostate in patients with pre-existing localized prostate cancer, dual center study","volume":"37","author":"Elsaqa","year":"2023","journal-title":"J Endourol"},{"key":"10.1016\/j.euf.2026.04.006_b0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/pros.24433","article-title":"Holmium laser enucleation of the prostate in men on active surveillance for prostate cancer with refractory lower urinary tract symptoms secondary to enlarged prostates","volume":"83","author":"Schober","year":"2023","journal-title":"Prostate"},{"key":"10.1016\/j.euf.2026.04.006_b0080","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.urology.2009.06.039","article-title":"Prostatic-specific antigen velocity after holmium laser enucleation of the prostate: possible predictor for the assessment of treatment effect durability for benign prostatic hyperplasia and detection of malignancy","volume":"74","author":"Elmansy","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.euf.2026.04.006_b0085","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/s41391-024-00909-w","article-title":"Prostate cancer screening and management in patients candidate for endoscopic enucleation of the prostate: an international survey","volume":"28","author":"Uleri","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456926000568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456926000568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:59:30Z","timestamp":1794434370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456926000568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2405456926000568"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2026.04.006","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cPro\/ \u2018Yes\u2019 for PSA Testing Before BPO Surgical Therapy\u201d Ignoring PSA in BPE is Not Progress; It\u2019s Clinical Blindness","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2026.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}